Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLX ?3.75 RB, SLActive? 10mm, RXD: medical device reports filed with FDA

5,707 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

5,707
device reports naming the brand
0% of all MAUDE reports · about 762 a year
1,278
reports, 12 months to August 2026
1,193 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

5,707 medical device reports received by FDA name the brand "BLX ?3.75 RB, SLActive? 10mm, RXD" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from January 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

1,278 reports arrived in the 12 months to August 2026, close to the 1,193 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (73.8%), loss of osseointegration (17.4%) and difficult to insert (0.8%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0139277Sep 2021: 30Oct 2021: 45Nov 2021: 72Dec 2021: 312022Jan 2022: 55Feb 2022: 54Mar 2022: 55Apr 2022: 71May 2022: 73Jun 2022: 57Jul 2022: 52Aug 2022: 71Sep 2022: 56Oct 2022: 54Nov 2022: 69Dec 2022: 742023Jan 2023: 83Feb 2023: 80Mar 2023: 59Apr 2023: 85May 2023: 56Jun 2023: 54Jul 2023: 61Aug 2023: 80Sep 2023: 80Oct 2023: 92Nov 2023: 88Dec 2023: 812024Jan 2024: 57Feb 2024: 88Mar 2024: 70Apr 2024: 88May 2024: 90Jun 2024: 68Jul 2024: 73Aug 2024: 77Sep 2024: 89Oct 2024: 123Nov 2024: 143Dec 2024: 1022025Jan 2025: 80Feb 2025: 74Mar 2025: 91Apr 2025: 39May 2025: 0Jun 2025: 277Jul 2025: 79Aug 2025: 96Sep 2025: 86Oct 2025: 125Nov 2025: 97Dec 2025: 1122026Jan 2026: 82Feb 2026: 94Mar 2026: 120Apr 2026: 118May 2026: 113Jun 2026: 99Jul 2026: 124Aug 2026: 108

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

05781,1562019: 16620192020: 31220202021: 50720212022: 74120222023: 89920232024: 1,06820242025: 1,15620252026: 8582026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%5,707
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report86.1%4,913
Voluntary report0%0
User facility report0%0
Distributor report13.9%794
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate4,21373.8%62.8%
Loss of osseointegration99117.4%22.4%
Difficult to insertthe device was hard to insert440.8%0.4%
Fracturea broken bone190.3%1.6%
Separation failure90.2%0.1%
Difficult to removethe device was hard to remove70.1%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis1,88533%
Painpain, site not specified1,14720.1%
Inflammationinflammation3456%
Tissue damage2935.1%
Hemorrhage/blood loss/bleeding2574.5%
Swelling/ edema2123.7%
Fistula1372.4%
Hyperresponsive to stimuli1182.1%
Abscessa collection of pus911.6%
Hypersensitivity/allergic reaction621.1%
Sinus perforation280.5%
Swellingswelling220.4%
Failure of implant190.3%
Inadequate osseointegration80.1%
Numbnessnumbness70.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLX ?3.75 RB, SLActive? 10mm, RXDProduct code DZEAll MAUDE reports
Reports5,7073,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer86.1%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLX ?3.75 RB, SLActive? 10mm, RXD reports

How many FDA reports name BLX ?3.75 RB, SLActive? 10mm, RXD?

5,707 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 1,278 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (73.8%), loss of osseointegration (17.4%), difficult to insert (0.8%), fracture (0.3%) and separation failure (0.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (86.1%) and distributor reports (13.9%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLX ?3.75 RB, SLActive? 10mm, RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.